Clinical Trials List
2021-03-01 - 2026-12-31
Phase III
Recruiting5
ICD-10N05.9
Unspecified nephritic syndrome with unspecified morphologic changes
ICD-9583.0
Nephritis and nephropathy, not specified as acute or chronic, with lesion of proliferative glomerulonephritis
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 詹傑凱 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 楊紹佑 無
- 黃道民 無
- FAN-CHI CHANG 無
- - - 無
- 陳怡婷 無
- CHUN-FU LAI 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chia-Te Liao Division of Nephrology
- Mei-Yi Wu Division of Nephrology
- YUNG-HO HSU Division of Nephrology
- I-jen Chiu Division of Nephrology
- Cai-Mei Zheng Division of Nephrology
- Li-Yee Hong Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
320 participants
